Abstract
There are other urologic malignancies that can be seen in the geriatric population. Of those discussed in this chapter, penile cancers are likely the most common that will be encountered in this age group, and early diagnosis and treatment are essential in order to optimize outcomes. Testicular neoplasms, also discussed herein, are not as common but do occur and are usually associated with a good prognosis, although secondary malignancies at this site require different treatment algorithms compared to germ cell tumors. Urethral cancers of both the male and female are exceedingly rare and associated with a poor prognosis unless diagnosed at an early stage. Evaluation and management for these cancers is not different in other age groups; however, comorbid diseases may complicate treatment and outcomes. Lastly, within this group long-term complications of radiation therapy are increasingly seen affecting other organ systems as well as health-related quality of life.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
National Cancer Institute. Testicular Cancer. Available at: http://www.cancer.gov/cancertopics/types/testicular
National Cancer Institute. SEER Database SEER Stat Fact Sheets: Testes Available at: http://seer.cancer.gov/statfacts/html/testis.html
Dieckmann KP, Pichlmeier U. Clinical epidemiology of testicular germ cell tumors. World J Urol. 2004;22:2–14.
Akre O, Pettersson A, Richiardi L. Risk of contralateral testicular cancer among men with unilaterally undescended testis: a meta analysis. Intl J Cancer. 2009;124(3):687–9.
Pettersson A, Richiardi L, Nordenskjold A, Kaijser M, Akre O. Age at surgery for undescended testis and risk of testicular cancer. N Engl J Med. 2007;356:1835–41.
Wanderas EH, Fossa SD, Tretli S. Risk of second germ cell cancer after treatment of a primary germ cell tumor in 2201 Norwegian male patients. Eur J Can. 1997;33:244–52.
Greene MH, Kratz CP, Mai PL. Familial testicular germ cell tumors in adults: 2010 summary of genetic risk factors and clinical phenotype. Endocr Relat Cancer. 2010;17(2):109–21.
Testis (2010) In: Edge SE, Byrd DR, Compton CC, et al., (eds). AJCC cancer staging manual. 7th ed. Springer, New York, NY pp 469–473
Fernandez EB, Moul JW, Foley JP, Colon E, McLeod DG. Retroperitoneal imaging with third and fourth generation computed axial tomography in clinical stage I nonseminomatous germ cell tumors. Urology. 1994;44:548–52.
Stephenson AJ, Gilligan TD. Neoplasms of the testis. In: Kavoussi LR, Novick AC, Partin AW, Peters CA, Wein A, editors. Campbell-Walsh urology. 10th ed. Philadelphia: Saunders; 2011. p. 848. Ch 31.
Salem M, Gilligan T. Serum tumor markers and their utilization in the management of germ-cell tumors in adult males. Exper Rev Anticancer Ther. 2011;11:1–4.
Yoon G, Stein J, Skinner D. Retroperitoneal lymph node dissection in the treatment of low-stage nonseminomatous germ cell tumors of the testicle: an update. Urol Oncol. 2005;23(3):168–77.
Berney DM, Warren AY, Verma M, et al. Malignant germ cell tumors in the elderly: a histopathological review of 50 cases in men aged 60 years or older. Mod Pathol. 2008;21:54–9.
Chung PW, Bayley AJ, Sweet J, et al. Spermatocytic seminoma: a review. Eur Urol. 2004;45:495–8.
Capitanio U, Jeldres C, Perrotte P, et al. Population-based study of perioperative mortality after retroperitoneal lymphadenectomy for nonseminomatous testicular germ cell tumors. Urology. 2009;74:373–7.
Chekol S, Chen-Chin S. Malignant mesothelioma of the tunica vaginalis testis: diagnostic studies and differential diagnosis. Arch Pathol Lab Med. 2012;136:113–7.
Ikegami Y, Kawai N, Tozawa K, Hayashi Y, Kohri K. Malignant mesothelioma of the tunica vaginalis testis related to recent asbestos. Int J Urol. 2008;15:560–1.
Abe K, Kato N, Miko K, et al. Malignant mesothelioma of testicular tunica vaginalis. Int J Urol. 2002; 9(10):602–3.
Darby S, Hancock B. Localised non-Hodgkin lymphoma of the testis: The Sheffield Lymphoma Group Experience. Int J Oncol. 2005;26:1093–9.
Kemmerling R, Stintzing S, Mühlmann J, Dietze O, Neureiter D. Primary testicular lymphoma: a strictly homogenous hematological disease? Onc Reports. 2010;23:1261–7.
Vural F, Cagirgan S, Saydam G, Hekimgil M, Soyer NA, Tombuloglu M. Primary testicular lymphoma. J Natl Med Assoc. 2007;99:1277–82.
Anghel G, Petti N, Remotti D, Ruscio C, Blandino F, Majolino I. Testicular plasmacytoma: report of a case and review of the literature. Am J Hem. 2002;71:98–104.
American Cancer Society: Cancer Facts and Figures 2012. Available at: http://www.cancer.org/Cancer/PenileCancer/DetailedGuide/penile-cancer-key-statistics
Hernandez BY, Barnholtz-Sloan J, German RR, et al. Burden of invasive squamous cell carcinoma of the penis in the United States, 1998–2003. Cancer. 2008;113:2883–91.
Bunker CB. Skin conditions of the male genitalia. Medicine. 2010;38(6):294–9.
Zollo JD, Zeitouni NC. The Roswell Park Cancer Institute experience with extramammary Paget’s disease. Br J Dermatol. 2000;142:59–65.
Doraiswamy V, Biboa J, Obafemi A, Goldschmid M. Leukocytosis and hypercalcemia: a rare combination of paraneoplastic features in squamous cell penile cancer. South Med J. 2010;103:474–6.
Buddington WT, Kickham CJ, Smith WE. An assessment of malignant disease of the penis. J Urol. 1963;89:442–9.
Lucky MA, Rogers B, Parr NJ. Referrals into a dedicated British penile cancer centre and sources of possible delay. Sex Transm Infect. 2009;85:527–30.
Bleeker MC, Heideman DA, Snijders PJ, Horenblas S, Dillner J, Meijer CJ. Penile cancer: epidemiology, pathogenesis and prevention. World J Urol. 2009;27:141–50.
Chaux A, Cubilla A. Diagnosis, epidemiology, and pathology of penile cancer. In: Scardino P, Linehan W, Zelefsky M, Vogelzang N, editors. Comprehensive textbook of genitourinary oncology. Philadelphia, PA: Lippincott Williams & Wilkins; 2011. p. 805–8.
Miralles-Guri C, Bruni L, Cubilla AL, Castellsague X, Bosch FX, De Sanjose S. Human papilloma virus prevalence and type distribution in penile carcinoma. J Clin Pathol. 2009;62:870–8.
Daling JR, Madeleine MM, Johnson LG, et al. Penile cancer: importance of circumcision, human papillomavirus and smoking in in situ and invasive disease. Int J Cancer. 2005;116:606–16.
Velazquez EF, Barreto JE, Rodriguez I, Piris A, Cubilla AL. Limitations in the interpretation of biopsies in patients with penile squamous cell carcinoma. Int J Surg Pathol. 2004;12:139–46.
Horenblas S, Van Tinteren H, Delemarre JF, Moonen LM, Lustig V, Kröger R. Squamous cell carcinoma of the penis: accuracy of tumor, nodes and metastases classification system and role of lymphangiography, computerized tomography scan, and fine needle aspiration cytology. J Urol. 1991;146:1279–83.
Solsona E, Algaba F, Horenblas S, Pizzocaro G, Windahi T. EAU guidelines on penile cancer. Eur Urol. 2004;46:1–8.
Penis (2010) In: Edge SB, Byrd DR, Compton CC, et al (eds) AJCC cancer staging manual. 7th ed. Springer, New York, NY pp 447–455
Agrawal A, Pai D, Ananthakrishnan N, Smile SR, Ratnakar C. The histological extent of the local spread of carcinoma of the penis and its therapeutic implications. BJU Int. 2000;85:299–301.
Horenblas S, van Tinteren H, Delemarre JF, Boon TA, Moonen LM, Lustig V. Squamous cell carcinoma of the penis II: treatment of the primary tumor. J Urol. 1992;147:1533–8.
Souillac I, Avances C, Camparo P, et al. Penile cancer in 2010: update from the oncology committee of the French Association of Urology: External Genital Organs Group (CCAFU-OGE). Prog Urol. 2011;21:909–16.
Schlenker B, Tilki D, Seitz M, et al. Organ-preserving neodymium-yttrium-aluminum-garnet laser therapy for penile carcinoma: a long-term follow-up. BJU Int. 2010;106:786–90.
Colecchia M, Nicolai N, Secchi P, et al. pT1 penile squamous cell carcinoma: a clinicopathologic study of 56 cases treated by CO2 laser therapy. Anal Quant Cytol Histol. 2009;31:153–60.
Mohs FE, Snow SN, Larson PO. Mohs micrographic surgery for penile tumors. Urol Clin North Am. 1992;19:291–304.
Crook J. Radiation therapy for penile cancer. In: Scardino P, Linehan W, Zelefsky M, Vogelzang N, editors. Comprehensive textbook of genitourinary oncology. Philadelphia, PA: Lippincott Williams & Wilkins; 2011. p. 823–9. Chapter 48.
McDougall WS, Kirchner FK, Edwards RH, Killion LT. Treatment of carcinoma of the penis. The case for primary lymphadenectomy. J Urol. 1986;136:38–41.
Lynch D. Urethral cancer. AUA Update Ser. 2006;25:109–16.
Swartz M, Porter M, Lin D, Weiss N. Urology incidence of primary urethral carcinoma in the United States. Urology. 2006;68:1164–8.
Rabbani F. Prognostic factors in male urethral cancer. Cancer. 2011;117:2426–34.
Wiener J, Walther P. A high association of oncogenic human papilloma viruses with carcinomas of the female urethra: polymerase chain reaction-based analysis of multiple histological types. J Urol. 1994;151:49–53.
Urethra (2010) In: Edge SB, Byrd DR, Compton CC, et al (eds.) American Joint Committee on Cancer Staging Manual, 7th, Springer, New York p 507
Dimarco DS, Dimarco CS, Zincke H, et al. Surgical treatment for local control of female urethral carcinoma. Urol Oncol. 2004;22:404–9.
Zhang N, Gong K, Zhang X, et al. Extramammary Paget’s disease of the scrotum – report of 25 cases and literature review. Urol Oncol. 2010;28:28–33.
Chattopadhyay M, Sterling J. Skin diseases affecting the vulva. Obstetr Gynaecol Reprod Med. 2011;21(6):169–75.
Chan JYW, Li GKH, Chung JHP, Chow VLY. Extramammary Paget’s disease: 20 years of experience in Chinese population. Int J Surg Oncol. 2012; article ID: 416418.
Fanning J, Lambert HC, Hale TM. Paget’s disease of the vulva: prevalence of associated vulvar adenocarcinoma, invasive Paget's disease, and recurrence after surgical excision. Am J Obstet Gynecol. 1999;180(1 Pt 1):24–7.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer Science+Business Media New York
About this chapter
Cite this chapter
Griffin, J., Mirza, M. (2014). Penis, Testis, Urethra, and Other Genitourinary Malignancies. In: Griebling, T. (eds) Geriatric Urology. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-9047-0_20
Download citation
DOI: https://doi.org/10.1007/978-1-4614-9047-0_20
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4614-9046-3
Online ISBN: 978-1-4614-9047-0
eBook Packages: MedicineMedicine (R0)